Literature DB >> 26241327

Development of a Weighted Cardiometabolic Disease Staging (CMDS) System for the Prediction of Future Diabetes.

Fangjian Guo1, W Timothy Garvey1.   

Abstract

CONTEXT: Metabolic syndrome traits are important risk factors for diabetes; however, each trait has different predictive power for future diabetes. Additionally, the impact of insulin resistance on metabolic profile can differ by gender and racial group, suggesting that gender-race specific prediction algorithms for diabetes may be warranted.
OBJECTIVE: To develop a quantitative scoring system based on weighting of risk components in the cardiometabolic disease staging (CMDS) system for the prediction of future diabetes. DESIGN, SETTING, AND PARTICIPANTS: We derived the CMDS score in 2857 participants with valid follow-up information on incident diabetes from the Coronary Artery Risk Development in Young Adults study and validated it in 6425 older participants from the Atherosclerosis Risk in Communities study. We assigned a simple integer value for each CMDS risk factor component. MAIN OUTCOME MEASURES: Incident diabetes.
RESULTS: Fasting glucose, 2-hour glucose, waist circumference, and blood pressure components contributed similarly for the prediction of future diabetes (CMDS scores, 23, 21, 26, and 20, respectively). The area under the receiver operating characteristic curve was 0.7158 for the CMDS scoring system, whereas it was 0.7053 for the Framingham diabetes score. The CMDS components performed differently for prediction of future diabetes in Black and White men and women. The components with the highest predictive power for diabetes were waist circumference in Black men, 2-hour glucose in Black women, and fasting glucose in both White men and White women.
CONCLUSIONS: The weighted CMDS score has high model discrimination power for diabetes and can be used clinically to identify patients for weight loss therapy based on differential risk for future diabetes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26241327      PMCID: PMC4596035          DOI: 10.1210/jc.2015-2691

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

1.  American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine.

Authors:  Jeffrey I Mechanick; Alan J Garber; Yehuda Handelsman; W Timothy Garvey
Journal:  Endocr Pract       Date:  2012 Sep-Oct       Impact factor: 3.443

Review 2.  New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approach.

Authors:  W Timothy Garvey
Journal:  Endocr Pract       Date:  2013 Sep-Oct       Impact factor: 3.443

3.  Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.

Authors:  Katherine M Flegal; Margaret D Carroll; Brian K Kit; Cynthia L Ogden
Journal:  JAMA       Date:  2012-01-17       Impact factor: 56.272

4.  Prevalence of childhood and adult obesity in the United States, 2011-2012.

Authors:  Cynthia L Ogden; Margaret D Carroll; Brian K Kit; Katherine M Flegal
Journal:  JAMA       Date:  2014-02-26       Impact factor: 56.272

5.  Obesity and risk factors for cardiovascular disease and type 2 diabetes: investigating the role of physical activity and sedentary behaviour in mid-life in the 1958 British cohort.

Authors:  Chris Power; Snehal M Pinto Pereira; Catherine Law; Myung Ki
Journal:  Atherosclerosis       Date:  2014-01-27       Impact factor: 5.162

Review 6.  Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis.

Authors:  Katherine M Flegal; Brian K Kit; Heather Orpana; Barry I Graubard
Journal:  JAMA       Date:  2013-01-02       Impact factor: 56.272

7.  Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans.

Authors:  Veeradej Pisprasert; Katherine H Ingram; Maria F Lopez-Davila; A Julian Munoz; W Timothy Garvey
Journal:  Diabetes Care       Date:  2012-12-06       Impact factor: 19.112

8.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

9.  The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity.

Authors:  Fangjian Guo; Douglas R Moellering; W Timothy Garvey
Journal:  Obesity (Silver Spring)       Date:  2013-09-05       Impact factor: 5.002

10.  BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans.

Authors:  Anna E Thalacker-Mercer; Katherine H Ingram; Fangjian Guo; Olga Ilkayeva; Christopher B Newgard; W Timothy Garvey
Journal:  Diabetes       Date:  2013-10-15       Impact factor: 9.461

View more
  11 in total

1.  Classification of obesity, cardiometabolic risk, and metabolic syndrome in adults with spinal cord injury.

Authors:  Amy M Yahiro; Brooks C Wingo; Sujit Kunwor; Jason Parton; Amy C Ellis
Journal:  J Spinal Cord Med       Date:  2019-01-08       Impact factor: 1.985

2.  Obesity: Obesity and cardiometabolic disease - more than meets the eye.

Authors:  Stella Aslibekyan; W Timothy Garvey
Journal:  Nat Rev Endocrinol       Date:  2017-09-01       Impact factor: 43.330

3.  Exploring a Need for a Cardiometabolic Disease Staging System as a Computerized Clinical Decision Support Tool: Qualitative Study.

Authors:  Aizhan Karabukayeva; Jami L Anderson; Allyson G Hall; Sue S Feldman; Tapan Mehta
Journal:  JMIR Form Res       Date:  2022-07-01

4.  Associations between cardiometabolic disease severity, social determinants of health (SDoH), and poor COVID-19 outcomes.

Authors:  Carrie R Howell; Li Zhang; Nengjun Yi; Tapan Mehta; Andrea L Cherrington; W Timothy Garvey
Journal:  Obesity (Silver Spring)       Date:  2022-05-25       Impact factor: 9.298

Review 5.  Metabolically healthy obesity: facts and fantasies.

Authors:  Gordon I Smith; Bettina Mittendorfer; Samuel Klein
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

6.  Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release.

Authors:  Fangjian Guo; W Timothy Garvey
Journal:  Diabetes Care       Date:  2017-04-28       Impact factor: 19.112

7.  The Need for Ethnoracial Equity in Artificial Intelligence for Diabetes Management: Review and Recommendations.

Authors:  Quynh Pham; Anissa Gamble; Jason Hearn; Joseph A Cafazzo
Journal:  J Med Internet Res       Date:  2021-02-10       Impact factor: 5.428

8.  Race Versus Social Determinants of Health in COVID-19 Hospitalization Prediction.

Authors:  Carrie R Howell; Li Zhang; Nengjun Yi; Tapan Mehta; W Timothy Garvey; Andrea L Cherrington
Journal:  Am J Prev Med       Date:  2022-07       Impact factor: 6.604

9.  Response to "The Future of Obesity Diagnostic Coding".

Authors:  W Timothy Garvey; Jeffrey I Mechanick
Journal:  Obesity (Silver Spring)       Date:  2020-06-09       Impact factor: 5.002

10.  Development and validation of a model for predicting incident type 2 diabetes using quantitative clinical data and a Bayesian logistic model: A nationwide cohort and modeling study.

Authors:  Lua Wilkinson; Nengjun Yi; Tapan Mehta; Suzanne Judd; W Timothy Garvey
Journal:  PLoS Med       Date:  2020-08-07       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.